Literature DB >> 20008295

Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity.

Josephine Losse1, Peter F Zipfel, Mihály Józsi.   

Abstract

The host complement system plays an important role in protection against infections. Several human-pathogenic microbes were shown to acquire host complement regulators, such as factor H (CFH), that downregulate complement activation at the microbial surface and protect the pathogens from the opsonic and lytic effects of complement. Because CFH can also bind to host cells, we addressed the role of CFH and CFH-related proteins as adhesion ligands in host-pathogen interactions. We show that the CFH family proteins CFH, CFH-like protein 1 (CFHL1), CFH-related protein (CFHR) 1, and CFHR4 long isoform bind to human neutrophil granulocytes and to the opportunistic human-pathogenic yeast Candida albicans. Two major binding sites, one within the N-terminus and one in the C-terminus of CFH, were found to mediate binding to neutrophils. Complement receptor 3 (CD11b/CD18; alpha(M)beta2 integrin) was identified as the major cellular receptor on neutrophils for CFH, CFHL1, and CFHR1, but not for CFHR4 long isoform. CFH and CFHR1 supported cell migration. Furthermore, CFH, CFHL1, and CFHR1 increased attachment of neutrophils to C. albicans. Adhesion of neutrophils to plasma-opsonized yeasts was reduced when CFH binding was inhibited by specific Abs or when using CFH-depleted plasma. Yeast-bound CFH and CFHR1 enhanced the generation of reactive oxygen species and the release of the antimicrobial protein lactoferrin by human neutrophils, and resulted in a more efficient killing of the pathogen. Thus, CFH and CFHR1, when bound on the surface of C. albicans, enhance antimicrobial activity of human neutrophils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008295     DOI: 10.4049/jimmunol.0901702

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 2.  Complement in monoclonal antibody therapy of cancer.

Authors:  Laura M Rogers; Suresh Veeramani; George J Weiner
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  Looking into Candida albicans infection, host response, and antifungal strategies.

Authors:  Yan Wang
Journal:  Virulence       Date:  2015-01-15       Impact factor: 5.882

4.  Candida albicans Hgt1p, a multifunctional evasion molecule: complement inhibitor, CR3 analogue, and human immunodeficiency virus-binding molecule.

Authors:  Iwona Lesiak-Markowicz; Georgia Vogl; Tobias Schwarzmüller; Cornelia Speth; Cornelia Lass-Flörl; Manfred P Dierich; Karl Kuchler; Reinhard Würzner
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

5.  Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.

Authors:  Mario Hebecker; Mihály Józsi
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

6.  Factor H facilitates adherence of Neisseria gonorrhoeae to complement receptor 3 on eukaryotic cells.

Authors:  Sarika Agarwal; Sanjay Ram; Jutamas Ngampasutadol; Sunita Gulati; Peter F Zipfel; Peter A Rice
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

7.  Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.

Authors:  Laura M Rogers; Sarah L Mott; Brian J Smith; Brian K Link; Deniz Sahin; George J Weiner
Journal:  Clin Cancer Res       Date:  2016-08-15       Impact factor: 12.531

8.  Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi M Riihilä; Liisa M Nissinen; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2013-08-12       Impact factor: 8.551

9.  Fibulin-1 purification from human plasma using affinity chromatography on Factor H-Sepharose.

Authors:  Richard G DiScipio; Robert C Liddington; Ingrid U Schraufstatter
Journal:  Protein Expr Purif       Date:  2016-01-28       Impact factor: 1.650

10.  CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.

Authors:  Guoliang Cui; Le Geng; Li Zhu; Zhenyan Lin; Xuan Liu; Zhengyue Miao; Jintao Jiang; Xiaoke Feng; Fei Wei
Journal:  J Cancer       Date:  2021-04-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.